Palo Capital’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Palo Capital's ELV Position: Q4 2018 in Review
Palo Capital reduced its Elevance Health (ELV) stake by 0.97% in Q4 2018, selling an estimated $59.1K and leaving 21,965 shares worth $5.77M. The position accounts for 2.45% of the portfolio, ranked #2.
Palo Capital first reported a position in ELV in Q4 2014 and has held it in 17 quarters since. The position peaked at $6.08M in Q3 2018. 997 funds tracked by Wall St. Rank hold ELV as of Q4 2018.
- Palo Capital held 21,965 shares of Elevance Health worth $5.77M as of Q4 2018.
- Palo Capital sold 215 Elevance Health shares in Q4 2018, an estimated $59.1K.
- Elevance Health made up 2.45% of Palo Capital's portfolio in Q4 2018, its #2 holding.
- Palo Capital first reported a position in Elevance Health in Q4 2014 and has held it in 17 quarters since.
- Palo Capital's Elevance Health position peaked at $6.08M in Q3 2018.
- 997 funds tracked by Wall St. Rank held Elevance Health as of Q4 2018.
Based on Palo Capital's 13F filing for Q4 2018, filed 30 Jan 2019.